Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Joe who wrote (1489)	8/14/1998 1:38:00 PM
From: admr	Read Replies (1) \| Respond to of 4140

Thank you. I found out that 6 of the 7 laser companies that make the excimer laser pay visx a one time fee for every laser placed internationally, about $20,000. However, in the U.S. visx expects to be paid for each procedure. The amount I don't know. Atci seems to feel that they can beat visx on the patent, however they plan to place the lasers for nothing, maintain the lasers and charge $400 per procedure. They then plan to escrow $250 pending the outcome of any litigation with visx. It seems to me that visx is clearly in the drivers seat with its patent on the excimer laser. Snrs, clearly, if ltk becomes the treatment of choice for hyperopia, presbyopia, would seem to have a similar potential.